Noninvasive ventilation in patients with COVID-19 from the perspective of the risk of contamination: a narrative review.
Expert Rev Respir Med
; 16(1): 67-77, 2022 01.
Article
in English
| MEDLINE | ID: covidwho-1585329
ABSTRACT
INTRODUCTION:
noninvasive ventilation (NIV) can be a useful resource to treat acute respiratory failure (ARF), which occurs in patients with COVID-19. However, it is important to consider that there are still no clinical studies that have verified the safety of its use in increase of contamination. AREAS COVERED Given the potential benefits and simultaneous concerns over the use of NIV in patients with COVID-19, further inquiry is necessary to reach a clinical consensus and provide recommendations for safe use, avoiding contamination. In this context, this narrative review, which included articles published in the Embase, SciELO, PEDro, PubMed and Cochrane up to August 2021, is focused to evaluate available studies related to interfaces, types of circuits, recommended filters, cares for the environment and protective factors for NIV use in patients with COVID-19. EXPERT OPINION The studies analyzed recommend that the use of NIV can be safe 1) with equipment that allows the use of the helmet as a safer interface; 2) with double circuit and antimicrobial filter in the expiratory branch; 3) in an environment that allows negative pressure, reducing the dispersion of aerosol particles in the environment; 4) the health team must use the recommended PPE to avoid contamination.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Respiratory Distress Syndrome
/
Respiratory Insufficiency
/
Noninvasive Ventilation
/
COVID-19
Type of study:
Etiology study
/
Experimental Studies
/
Prognostic study
/
Reviews
Limits:
Humans
Language:
English
Journal:
Expert Rev Respir Med
Year:
2022
Document Type:
Article
Affiliation country:
17476348.2021.2011223
Similar
MEDLINE
...
LILACS
LIS